Veteran private-equity and corporate development executive focused on operational value creation, portfolio management and capital strategy across growth and middle-market buyouts. Brian W. Rahlfs brings experience leading deal execution, LP relations and post-acquisition integration in sectors including industrials and services. Tracks sponsor-led restructurings, operational improvement programs, and capital markets interfacing; frequently cited by investors for pragmatic, execution-oriented leadership.
Veteran private-equity and corporate development executive focused on operational value creation, portfolio management and capital strategy across growth and middle-market buyouts. Brian W. Rahlfs brings experience leading deal execution, LP relations and post-acquisition integration in sectors including industrials and services. Tracks sponsor-led restructurings, operational improvement programs, and capital markets interfacing; frequently cited by investors for pragmatic, execution-oriented leadership.
Focuses on operationally-driven private equity investing in growth and middle-market buyouts, prioritizing deep due diligence, hands-on post-acquisition integration, and measurable margin expansion. Capital allocation favors sponsor-led restructurings and owner-operated industrials and services where operational levers and management alignment accelerate value. Combines conservative leverage, tranche-driven capital structure, and LP-focused communication to balance downside protection with multi-year value creation horizons. Decision-making emphasizes pragmatic execution, portfolio-level oversight, and clear exit path discipline.
Focuses on operationally-driven private equity investing in growth and middle-market buyouts, prioritizing deep due diligence, hands-on post-acquisition integration, and measurable margin expansion. Capital allocation favors sponsor-led restructurings and owner-operated industrials and services where operational levers and management alignment accelerate value. Combines conservative leverage, tranche-driven capital structure, and LP-focused communication to balance downside protection with multi-year value creation horizons. Decision-making emphasizes pragmatic execution, portfolio-level oversight, and clear exit path discipline.
| Trades 273 | Longs Won 180/273 65% | Profit Factor 8.51 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $429,178.06 |
| Average Win $219,316.14 | Best Trade (Oct 15) $3.38M | Sharpe Ratio -12.02 |
| Average Loss -$49,858.57 | Worst Trade (Oct 15) -$476,776 | Z-Score 4.3 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2w 5d | Expectancy $127,619.26 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 2,924 | 2,632 | 2,339 | 2,047 | 1,754 | 1,462 | 1,170 | 877 | 585 | 292 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 37,020 | $9.27M | $12.66M | - | $3.38M | 36.5% | -0.292% |
ABBV AbbVie Inc. | 5,899 | $1.05M | $1.68M | - | $632,815.53 | 60.37% | +0.527% |
ABT Abbott Laboratories | 7,165 | $810,432.86 | $749,960.55 | - | -$60,472.31 | -7.46% | +1.651% |
ADBE Adobe Inc. | 2,127 | $941,041.36 | $531,643.65 | - | -$409,397.71 | -43.5% | +3.852% |
ADM Archer-Daniels-Midland Co | 20,810 | $1.34M | $1.73M | - | $391,488.08 | 29.27% | -0.664% |
AFL Aflac Inc. | 1,897 | $200,057.87 | $224,263.34 | - | $24,205.47 | 12.1% | +0.008% |
AMGN Amgen Inc. | 840 | $218,938 | $369,272.4 | - | $150,334.4 | 68.67% | +3.168% |
AMZN Amazon.com Inc | 9,955 | $2.19M | $2.52M | - | $332,279.09 | 15.16% | -0.22% |
APA APA Corporation | 58,700 | $1.43M | $2.77M | - | $1.35M | 94.36% | -0.296% |
BAC Bank of America Corporation | 5,450 | $239,527.69 | $281,983 | - | $42,455.31 | 17.72% | +0.681% |
BMY Bristol-Myers Squibb Company | 19,851 | $1.12M | $1.21M | - | $84,565.41 | 7.53% | +2.598% |
BRK-B Berkshire Hathaway Inc. | 14,992 | $6.86M | $7.91M | - | $1.05M | 15.33% | +0.284% |
BSM Black Stone Minerals, L.P. | 100,062 | $1.44M | $1.48M | - | $39,549.44 | 2.75% | -0.169% |
COST Costco Wholesale Corporation | 540 | $494,786 | $534,600 | - | $39,814 | 8.05% | +0.815% |
CPNG Coupang Inc. | 34,525 | $852,675.48 | $507,862.75 | - | -$344,812.73 | -40.44% | +2.153% |
CRK Comstock Resources Inc. | 48,850 | $1.13M | $655,567 | - | -$476,776 | -42.11% | -2.044% |
CSCO Cisco Systems, Inc. | 4,200 | $248,640 | $457,548 | - | $208,908 | 84.02% | -4.136% |
CVS CVS Health Corporation | 5,930 | $266,198 | $545,945.45 | - | $279,747.45 | 105.09% | +1.853% |
CVX Chevron Corporation | 8,069 | $1.17M | $1.77M | - | $599,849.82 | 51.33% | -1.288% |
D Dominion Energy, Inc. | 12,050 | $681,066 | $757,824.5 | - | $76,758.5 | 11.27% | +0.143% |